Market Access

Find service providers for Market Access services in Europe. The list does not claim to be complete and no guarantee can be given for the correctness and up-to-dateness of the information provided. Furthermore, please note that this list does not have any recommendatory character.

If you are a provider of services in this area, you have the possibility to register free of charge in this directory.

Diapharm GmbH & Co. KG

Hafenweg 18-20

48155 Münster

Germany

info@diapharm.de

Homepage 

  • Consultancy and support in the planning of clinical trials
  • Support in planning and conducting G-BA consultations
  • Definition and evaluation of appropriate subgroups; identification of patient-relevant endpoints on the basis of existing data
  • Consultancy on value dossiers
  • Project management for the entire early benefit assessment process


ELC-Group s.r.o

Karolinská 650/1,

186 00 Prague 

Czech Republic 

info@elc-group.com

Homepage 

  • Establishing price-proposal & application at the Competent Authority
  • Reimbursement preparation & application at the Competent Authority
  • Complete market access dossiers including health economics cases
  • Analyse available and publically accessible reference prices of a product (price simulation)
  • Strategic advice on the possibilities for market access
  • Strategy determination for reimbursement
  • Global overview of market access for the product
  • Country specific market access road maps
  • Analysis of former examples and strategies implemented
  • Arrange preliminary communication about the product with Key Opinion Leader
  • Health Economic Modelling
  • Value Development Planning
  • Business development (sourcing companies to market products)


PharmaLex GmbH

Harrlachweg 6

68163 Mannheim

Germany 

Homepage

PharmaLex is a leading provider of specialized services for the pharma, biotech and medical device industries.

 

We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.

 

The PharmaLex Group now has over 1000 employees, with 33 offices in 21 countries and more than 600 satisfied clients worldwide.

  • HTA and P&R process
  • Stakeholder Landscape
  • Patient Pathway
  • HEOR
  • RWD / RWE / RWI
  • Scientific / Value Assessment
  • Pricing Models
  • Value Proposition
  • Value Creation / VBHC